AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?
Identifieur interne : 000B59 ( PubMed/Checkpoint ); précédent : 000B58; suivant : 000B60AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?
Auteurs : Leslie A. Reperant [Pays-Bas] ; Albert D M E. Osterhaus [Allemagne]Source :
- Vaccine [ 1873-2518 ] ; 2017.
Descripteurs français
- KwdFr :
- Afrique (épidémiologie), Animaux, Antiviraux, Asie (épidémiologie), Europe (épidémiologie), Fièvre hémorragique à virus Ebola (), Fièvre hémorragique à virus Ebola (transmission), Fièvre hémorragique à virus Ebola (épidémiologie), Grippe humaine (), Grippe humaine (transmission), Grippe humaine (épidémiologie), Humains, Infection par le virus Zika (), Infection par le virus Zika (transmission), Infection par le virus Zika (épidémiologie), Infections à coronavirus (), Infections à coronavirus (transmission), Infections à coronavirus (épidémiologie), Maladies transmissibles émergentes (), Maladies transmissibles émergentes (transmission), Maladies transmissibles émergentes (épidémiologie), Pandémies (), Santé mondiale (), Syndrome d'immunodéficience acquise (), Syndrome d'immunodéficience acquise (transmission), Syndrome d'immunodéficience acquise (épidémiologie), Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (transmission), Syndrome respiratoire aigu sévère (épidémiologie), Vaccins antiviraux, États-Unis d'Amérique (épidémiologie).
- MESH :
- épidémiologie : Afrique, Asie, Europe, Fièvre hémorragique à virus Ebola, Grippe humaine, Infection par le virus Zika, Infections à coronavirus, Maladies transmissibles émergentes, Syndrome d'immunodéficience acquise, Syndrome respiratoire aigu sévère, États-Unis d'Amérique.
- Animaux, Antiviraux, Fièvre hémorragique à virus Ebola, Grippe humaine, Humains, Infection par le virus Zika, Infections à coronavirus, Maladies transmissibles émergentes, Pandémies, Santé mondiale, Syndrome d'immunodéficience acquise, Syndrome respiratoire aigu sévère, Vaccins antiviraux.
English descriptors
- KwdEn :
- Acquired Immunodeficiency Syndrome (epidemiology), Acquired Immunodeficiency Syndrome (prevention & control), Acquired Immunodeficiency Syndrome (transmission), Africa (epidemiology), Animals, Antiviral Agents, Asia (epidemiology), Communicable Diseases, Emerging (epidemiology), Communicable Diseases, Emerging (prevention & control), Communicable Diseases, Emerging (transmission), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Coronavirus Infections (transmission), Europe (epidemiology), Global Health (statistics & numerical data), Hemorrhagic Fever, Ebola (epidemiology), Hemorrhagic Fever, Ebola (prevention & control), Hemorrhagic Fever, Ebola (transmission), Humans, Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (transmission), Pandemics (prevention & control), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (prevention & control), Severe Acute Respiratory Syndrome (transmission), United States (epidemiology), Viral Vaccines, Zika Virus Infection (epidemiology), Zika Virus Infection (prevention & control), Zika Virus Infection (transmission).
- MESH :
- chemical : Antiviral Agents, Viral Vaccines.
- epidemiology : Acquired Immunodeficiency Syndrome, Africa, Asia, Communicable Diseases, Emerging, Coronavirus Infections, Europe, Hemorrhagic Fever, Ebola, Influenza, Human, Severe Acute Respiratory Syndrome, United States, Zika Virus Infection.
- prevention & control : Acquired Immunodeficiency Syndrome, Communicable Diseases, Emerging, Coronavirus Infections, Hemorrhagic Fever, Ebola, Influenza, Human, Pandemics, Severe Acute Respiratory Syndrome, Zika Virus Infection.
- statistics & numerical data : Global Health.
- transmission : Acquired Immunodeficiency Syndrome, Communicable Diseases, Emerging, Coronavirus Infections, Hemorrhagic Fever, Ebola, Influenza, Human, Severe Acute Respiratory Syndrome, Zika Virus Infection.
- Animals, Humans.
Abstract
Emerging infections have threatened humanity since times immemorial. The dramatic anthropogenic, behavioral and social changes that have affected humanity and the environment in the past century have accelerated the intrusion of novel pathogens into the global human population, sometimes with devastating consequences. The AIDS and influenza pandemics have claimed and will continue to claim millions of lives. The recent SARS and Ebola epidemics have threatened populations across borders. The emergence of MERS may well be warning signals of a nascent pandemic threat, while the potential for geographical spread of vector-borne diseases, such as Zika, but also Dengue and Chikungunya is unprecedented. Novel technologies and innovative approaches have multiplied to address and improve response preparedness towards the increasing yet unpredictable threat posed by emerging pathogens.
DOI: 10.1016/j.vaccine.2017.04.082
PubMed: 28633891
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:28633891Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?</title><author><name sortKey="Reperant, Leslie A" sort="Reperant, Leslie A" uniqKey="Reperant L" first="Leslie A" last="Reperant">Leslie A. Reperant</name><affiliation wicri:level="3"><nlm:affiliation>Artemis One Health Research Foundation, Utrecht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Artemis One Health Research Foundation, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Osterhaus, Albert D M E" sort="Osterhaus, Albert D M E" uniqKey="Osterhaus A" first="Albert D M E" last="Osterhaus">Albert D M E. Osterhaus</name><affiliation wicri:level="3"><nlm:affiliation>Artemis One Health Research Foundation, Utrecht, The Netherlands; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine, Hannover, Germany. Electronic address: Albert.Osterhaus@tiho-hannover.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Artemis One Health Research Foundation, Utrecht, The Netherlands; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine, Hannover</wicri:regionArea><placeName><region type="land" nuts="2">Basse-Saxe</region><settlement type="city">Hanovre</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28633891</idno><idno type="pmid">28633891</idno><idno type="doi">10.1016/j.vaccine.2017.04.082</idno><idno type="wicri:Area/PubMed/Corpus">000B11</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B11</idno><idno type="wicri:Area/PubMed/Curation">000B11</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000B11</idno><idno type="wicri:Area/PubMed/Checkpoint">000B59</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B59</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?</title><author><name sortKey="Reperant, Leslie A" sort="Reperant, Leslie A" uniqKey="Reperant L" first="Leslie A" last="Reperant">Leslie A. Reperant</name><affiliation wicri:level="3"><nlm:affiliation>Artemis One Health Research Foundation, Utrecht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Artemis One Health Research Foundation, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Osterhaus, Albert D M E" sort="Osterhaus, Albert D M E" uniqKey="Osterhaus A" first="Albert D M E" last="Osterhaus">Albert D M E. Osterhaus</name><affiliation wicri:level="3"><nlm:affiliation>Artemis One Health Research Foundation, Utrecht, The Netherlands; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine, Hannover, Germany. Electronic address: Albert.Osterhaus@tiho-hannover.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Artemis One Health Research Foundation, Utrecht, The Netherlands; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine, Hannover</wicri:regionArea><placeName><region type="land" nuts="2">Basse-Saxe</region><settlement type="city">Hanovre</settlement></placeName></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acquired Immunodeficiency Syndrome (epidemiology)</term><term>Acquired Immunodeficiency Syndrome (prevention & control)</term><term>Acquired Immunodeficiency Syndrome (transmission)</term><term>Africa (epidemiology)</term><term>Animals</term><term>Antiviral Agents</term><term>Asia (epidemiology)</term><term>Communicable Diseases, Emerging (epidemiology)</term><term>Communicable Diseases, Emerging (prevention & control)</term><term>Communicable Diseases, Emerging (transmission)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (transmission)</term><term>Europe (epidemiology)</term><term>Global Health (statistics & numerical data)</term><term>Hemorrhagic Fever, Ebola (epidemiology)</term><term>Hemorrhagic Fever, Ebola (prevention & control)</term><term>Hemorrhagic Fever, Ebola (transmission)</term><term>Humans</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Influenza, Human (transmission)</term><term>Pandemics (prevention & control)</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Severe Acute Respiratory Syndrome (transmission)</term><term>United States (epidemiology)</term><term>Viral Vaccines</term><term>Zika Virus Infection (epidemiology)</term><term>Zika Virus Infection (prevention & control)</term><term>Zika Virus Infection (transmission)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Afrique (épidémiologie)</term><term>Animaux</term><term>Antiviraux</term><term>Asie (épidémiologie)</term><term>Europe (épidémiologie)</term><term>Fièvre hémorragique à virus Ebola ()</term><term>Fièvre hémorragique à virus Ebola (transmission)</term><term>Fièvre hémorragique à virus Ebola (épidémiologie)</term><term>Grippe humaine ()</term><term>Grippe humaine (transmission)</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Infection par le virus Zika ()</term><term>Infection par le virus Zika (transmission)</term><term>Infection par le virus Zika (épidémiologie)</term><term>Infections à coronavirus ()</term><term>Infections à coronavirus (transmission)</term><term>Infections à coronavirus (épidémiologie)</term><term>Maladies transmissibles émergentes ()</term><term>Maladies transmissibles émergentes (transmission)</term><term>Maladies transmissibles émergentes (épidémiologie)</term><term>Pandémies ()</term><term>Santé mondiale ()</term><term>Syndrome d'immunodéficience acquise ()</term><term>Syndrome d'immunodéficience acquise (transmission)</term><term>Syndrome d'immunodéficience acquise (épidémiologie)</term><term>Syndrome respiratoire aigu sévère ()</term><term>Syndrome respiratoire aigu sévère (transmission)</term><term>Syndrome respiratoire aigu sévère (épidémiologie)</term><term>Vaccins antiviraux</term><term>États-Unis d'Amérique (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antiviral Agents</term><term>Viral Vaccines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term><term>Africa</term><term>Asia</term><term>Communicable Diseases, Emerging</term><term>Coronavirus Infections</term><term>Europe</term><term>Hemorrhagic Fever, Ebola</term><term>Influenza, Human</term><term>Severe Acute Respiratory Syndrome</term><term>United States</term><term>Zika Virus Infection</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term><term>Communicable Diseases, Emerging</term><term>Coronavirus Infections</term><term>Hemorrhagic Fever, Ebola</term><term>Influenza, Human</term><term>Pandemics</term><term>Severe Acute Respiratory Syndrome</term><term>Zika Virus Infection</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Global Health</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term><term>Communicable Diseases, Emerging</term><term>Coronavirus Infections</term><term>Hemorrhagic Fever, Ebola</term><term>Influenza, Human</term><term>Severe Acute Respiratory Syndrome</term><term>Zika Virus Infection</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Afrique</term><term>Asie</term><term>Europe</term><term>Fièvre hémorragique à virus Ebola</term><term>Grippe humaine</term><term>Infection par le virus Zika</term><term>Infections à coronavirus</term><term>Maladies transmissibles émergentes</term><term>Syndrome d'immunodéficience acquise</term><term>Syndrome respiratoire aigu sévère</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Antiviraux</term><term>Fièvre hémorragique à virus Ebola</term><term>Grippe humaine</term><term>Humains</term><term>Infection par le virus Zika</term><term>Infections à coronavirus</term><term>Maladies transmissibles émergentes</term><term>Pandémies</term><term>Santé mondiale</term><term>Syndrome d'immunodéficience acquise</term><term>Syndrome respiratoire aigu sévère</term><term>Vaccins antiviraux</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Emerging infections have threatened humanity since times immemorial. The dramatic anthropogenic, behavioral and social changes that have affected humanity and the environment in the past century have accelerated the intrusion of novel pathogens into the global human population, sometimes with devastating consequences. The AIDS and influenza pandemics have claimed and will continue to claim millions of lives. The recent SARS and Ebola epidemics have threatened populations across borders. The emergence of MERS may well be warning signals of a nascent pandemic threat, while the potential for geographical spread of vector-borne diseases, such as Zika, but also Dengue and Chikungunya is unprecedented. Novel technologies and innovative approaches have multiplied to address and improve response preparedness towards the increasing yet unpredictable threat posed by emerging pathogens.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28633891</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>35 Pt A</Issue><PubDate><Year>2017</Year><Month>08</Month><Day>16</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?</ArticleTitle><Pagination><MedlinePgn>4470-4474</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(17)30583-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2017.04.082</ELocationID><Abstract><AbstractText>Emerging infections have threatened humanity since times immemorial. The dramatic anthropogenic, behavioral and social changes that have affected humanity and the environment in the past century have accelerated the intrusion of novel pathogens into the global human population, sometimes with devastating consequences. The AIDS and influenza pandemics have claimed and will continue to claim millions of lives. The recent SARS and Ebola epidemics have threatened populations across borders. The emergence of MERS may well be warning signals of a nascent pandemic threat, while the potential for geographical spread of vector-borne diseases, such as Zika, but also Dengue and Chikungunya is unprecedented. Novel technologies and innovative approaches have multiplied to address and improve response preparedness towards the increasing yet unpredictable threat posed by emerging pathogens.</AbstractText><CopyrightInformation>Copyright © 2017. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reperant</LastName><ForeName>Leslie A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Artemis One Health Research Foundation, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osterhaus</LastName><ForeName>Albert D M E</ForeName><Initials>ADME</Initials><AffiliationInfo><Affiliation>Artemis One Health Research Foundation, Utrecht, The Netherlands; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine, Hannover, Germany. Electronic address: Albert.Osterhaus@tiho-hannover.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000163" MajorTopicYN="Y">Acquired Immunodeficiency Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N">Asia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021821" MajorTopicYN="Y">Communicable Diseases, Emerging</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019142" MajorTopicYN="Y">Hemorrhagic Fever, Ebola</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="Y">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="Y">Zika Virus Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Emerging</Keyword><Keyword MajorTopicYN="Y">Epidemics</Keyword><Keyword MajorTopicYN="Y">Preparedness</Keyword><Keyword MajorTopicYN="Y">Virus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>04</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>04</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28633891</ArticleId><ArticleId IdType="pii">S0264-410X(17)30583-2</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2017.04.082</ArticleId><ArticleId IdType="pmc">PMC7115365</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sci Prog. 2008;91(Pt 1):1-37</Citation><ArticleIdList><ArticleId IdType="pubmed">18453281</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7</Citation><ArticleIdList><ArticleId IdType="pubmed">6096719</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 1983 May 20;220(4599):868-71</Citation><ArticleIdList><ArticleId IdType="pubmed">6189183</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2016 Jun 3;34(26):2976-2981</Citation><ArticleIdList><ArticleId IdType="pubmed">27026149</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Expert Rev Vaccines. 2016 Sep;15(9):1083-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27212079</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2012 Jun 22;30(30):4419-34</Citation><ArticleIdList><ArticleId IdType="pubmed">22537992</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS One. 2012;7(8):e42689</Citation><ArticleIdList><ArticleId IdType="pubmed">22905160</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>F1000Prime Rep. 2014 Jun 02;6:47</Citation><ArticleIdList><ArticleId IdType="pubmed">24991424</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2009 Nov;15(11):1849-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19891883</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2003 May 15;423(6937):240</Citation><ArticleIdList><ArticleId IdType="pubmed">12748632</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2431-41</Citation><ArticleIdList><ArticleId IdType="pubmed">14681510</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2010 Jan 2;375(9708):56-66</Citation><ArticleIdList><ArticleId IdType="pubmed">20018364</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2016 Jan 8;351(6269):aad2622</Citation><ArticleIdList><ArticleId IdType="pubmed">26744408</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2001 Jul 29;356(1411):991-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11516377</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Cell Host Microbe. 2014 Sep 10;16(3):328-37</Citation><ArticleIdList><ArticleId IdType="pubmed">25211075</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Antivir Ther. 2007;12(7):1107-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18018769</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19745214</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2016 Dec 8;540(7632):284-287</Citation><ArticleIdList><ArticleId IdType="pubmed">27841870</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2009 Dec 17;361(25):2424-35</Citation><ArticleIdList><ArticleId IdType="pubmed">19745215</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2013 Mar 14;495(7440):251-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23486063</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Curr Top Microbiol Immunol. 2013;365:281-98</Citation><ArticleIdList><ArticleId IdType="pubmed">22903569</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2016 Apr 21;374(16):1506-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26959308</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS Pathog. 2017 Jan 12;13(1):e1006037</Citation><ArticleIdList><ArticleId IdType="pubmed">28081225</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2009 Sep;15(9):1347-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19788800</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2012 Sep;12(9):687-95</Citation><ArticleIdList><ArticleId IdType="pubmed">22738893</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 1999 Feb 4;397(6718):436-41</Citation><ArticleIdList><ArticleId IdType="pubmed">9989410</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2009 Dec 17;361(25):2405-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19745216</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Curr Top Microbiol Immunol. 2013;365:49-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23042568</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2430-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15695582</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Med. 2004 Mar;10(3):290-3</Citation><ArticleIdList><ArticleId IdType="pubmed">14981511</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2016 Jan 1;351(6268):77-81</Citation><ArticleIdList><ArticleId IdType="pubmed">26678878</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Intervirology. 1982;18(1-2):24-32</Citation><ArticleIdList><ArticleId IdType="pubmed">7118520</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2005 Oct 28;310(5748):676-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16195424</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2008 Nov 25;26(50):6338-43</Citation><ArticleIdList><ArticleId IdType="pubmed">18824060</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Curr Opin Virol. 2012 Jun;2(3):330-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22709518</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Viruses. 2014 Apr 17;6(4):1759-88</Citation><ArticleIdList><ArticleId IdType="pubmed">24747773</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Pays-Bas</li></country><region><li>Basse-Saxe</li><li>Utrecht (province)</li></region><settlement><li>Hanovre</li><li>Utrecht</li></settlement></list><tree><country name="Pays-Bas"><region name="Utrecht (province)"><name sortKey="Reperant, Leslie A" sort="Reperant, Leslie A" uniqKey="Reperant L" first="Leslie A" last="Reperant">Leslie A. Reperant</name></region></country><country name="Allemagne"><region name="Basse-Saxe"><name sortKey="Osterhaus, Albert D M E" sort="Osterhaus, Albert D M E" uniqKey="Osterhaus A" first="Albert D M E" last="Osterhaus">Albert D M E. Osterhaus</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B59 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000B59 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:28633891
|texte= AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:28633891" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |